Panayotova-Heiermann M, Eskandari S, Turk E, Zampighi G A, Wright E M
Department of Physiology, UCLA Medical Center, Los Angeles, California 90095-1751, USA.
J Biol Chem. 1997 Aug 15;272(33):20324-7. doi: 10.1074/jbc.272.33.20324.
To test the hypothesis that the C-terminal half of the Na+/glucose cotransporter (SGLT1) contains the sugar permeation pathway, a cDNA construct (C5) coding for rabbit SGLT1 amino acids 407-662, helices 10-14, was expressed in Xenopus oocytes. Expression and function of C5 was followed by Western blotting, electron microscopy, radioactive tracer, and electrophysiological methods. The C5 protein was synthesized in 20-fold higher levels than SGLT1. The particle density in the protoplasmic face of the oocyte plasma membrane increased 2-fold after C5-cRNA injection compared with noninjected oocytes. The diameters of the C5 particles were heterogeneous (4.8 +/- 0.3, 7.1 +/- 1.2, and 10.3 +/- 0.8 nm) in contrast to the endogenous particles (7.6 +/- 1.2 nm). C5 increased the alpha-methyl-D-glucopyranoside (alphaMDG) uptake up to 20-fold above that of noninjected oocytes and showed an apparent K0.5alphaMDG of 50 mM and a turnover of approximately 660 s-1. Influx was independent of Na+ with transport characteristics similar to those of SGLT1 in the absence of Na+: 1) selective (alphaMDG > D-glucose > D-galactose >> L-glucose approximately D-mannose), 2) inhibited by phloretin, KiPT = approximately 500 microM, and 3) insensitive to phlorizin. These results indicate that C5 behaves as a specific low affinity glucose uniporter. Preliminary studies with three additional constructs, hC5 (the human equivalent of C5), hC4 (human SGLT1 amino acids 407-648, helices 10-13), and hN13 (amino acids 1-648, helices 1-13), further suggest that helices 10-13 form the sugar permeation pathway for SGLT1.
为了验证钠/葡萄糖共转运蛋白(SGLT1)的C端半段包含糖通透途径这一假说,编码兔SGLT1第407 - 662位氨基酸(第10 - 14个螺旋)的cDNA构建体(C5)在非洲爪蟾卵母细胞中表达。通过蛋白质印迹法、电子显微镜、放射性示踪法和电生理方法对C5的表达和功能进行追踪。C5蛋白的合成水平比SGLT1高20倍。与未注射的卵母细胞相比,注射C5 - cRNA后卵母细胞质膜原生质面的颗粒密度增加了2倍。与内源性颗粒(7.6±1.2 nm)不同,C5颗粒的直径具有异质性(4.8±0.3、7.1±1.2和10.3±0.8 nm)。C5使α - 甲基 - D - 吡喃葡萄糖苷(αMDG)的摄取量比未注射的卵母细胞增加了20倍,其表观K0.5αMDG为50 mM,周转数约为660 s-1。在没有Na+的情况下,内流不依赖于Na+,其转运特性与SGLT1相似:1)具有选择性(αMDG>D - 葡萄糖>D - 半乳糖>>L - 葡萄糖≈D - 甘露糖),2)被根皮素抑制,KiPT≈500 μM,3)对根皮苷不敏感。这些结果表明C5表现为一种特异性低亲和力葡萄糖单向转运体。对另外三个构建体hC5(C5的人类等同物)、hC4(人类SGLT1第407 - 648位氨基酸,第10 - 13个螺旋)和hN13(第1 - 648位氨基酸,第1 - 13个螺旋)的初步研究进一步表明,第10 - 13个螺旋构成了SGLT1的糖通透途径。